Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Oral and intestinal bacterial substances associated with disease activities in patients with rheumatoid arthritis: A cross-sectional clinical study
E., Burk, R
Novo Nordisk plans to report data from a global trial of UBT251 next year, Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development at Novo Nordisk, said in the statement
Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: a two-sample Mendelian randomization analysis of European and East Asian populations
Gain the predictable, real-world solutions you need to treat the root causes of sleep-breathing disorders and TMD
US$ 28.35
US$ 23.35
US$ 28.74
US$ 28.15
